- Home
- TERN vs SKT Comparison
TERN vs SKT Comparison
Compare TERN & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TERN | SKT |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | TERN | SKT |
|---|---|---|
| Price | $34.33 | $32.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $48.60 | $36.14 |
| AVG Volume (30 Days) | ★ 2.1M | 1.0M |
| Earning Date | 03-19-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 3.62% |
| EPS Growth | N/A | ★ 8.00 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $575,140,000.00 |
| Revenue This Year | N/A | $3.41 |
| Revenue Next Year | N/A | $4.68 |
| P/E Ratio | ★ N/A | $34.38 |
| Revenue Growth | N/A | ★ 10.01 |
| 52 Week Low | $1.87 | $28.69 |
| 52 Week High | $48.26 | $36.76 |
Technical Indicators
Market Signals| Indicator | TERN | SKT |
|---|---|---|
| Relative Strength Index (RSI) | 42.71 | 46.06 |
| Support Level | $33.60 | $32.13 |
| Resistance Level | $35.46 | $33.70 |
| Average True Range (ATR) | 1.93 | 0.65 |
| MACD | -0.56 | -0.11 |
| Stochastic Oscillator | 18.52 | 33.78 |
Price Performance
Historical ComparisonAbout TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.